Equities
Health CareMedical Equipment and Services
  • Price (USD)43.79
  • Today's Change0.21 / 0.48%
  • Shares traded3.52m
  • 1 Year change-31.28%
  • Beta1.1656
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

  • Revenue in USD (TTM)3.45bn
  • Net income in USD79.60m
  • Incorporated2000
  • Employees11.40k
  • Location
    Bruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
  • Phone+1 (978) 663-3660
  • Fax+1 (978) 663-5585
  • Websitehttps://www.bruker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BRKR:NSQ since
announced
Transaction
value
Recipe Chemicals Instruments GmbhDeal completed16 Apr 202516 Apr 2025Deal completed13.95%--
Dynamic Biosensors GmbHDeal completed02 Oct 202402 Oct 2024Deal completed-34.41%--
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Integer Holdings Corp1.75bn78.00m4.19bn11.00k56.422.6021.802.402.132.1049.3346.050.54454.874.94158,744.702.433.282.603.5427.1026.704.476.382.144.300.43960.0010.356.4135.805.8216.99--
Irhythm Technologies Inc618.59m-98.32m4.34bn2.00k--50.06--7.02-3.14-3.1419.742.720.673912.977.26309,293.50-10.71-20.12-12.08-24.3769.3968.61-15.89-23.905.58--0.8819--20.1322.508.20--19.06--
Teleflex Inc3.01bn149.53m5.14bn14.10k36.661.2712.091.713.183.1764.5091.670.41122.106.59213,485.402.044.582.235.0155.6854.774.9711.381.327.590.317819.742.453.26-80.38-31.404.250.00
Merit Medical Systems Inc1.39bn122.26m5.53bn7.40k45.853.8722.783.982.042.0423.1224.180.57922.347.30187,615.805.103.495.543.9347.8045.378.815.653.2624.200.33840.007.896.4027.4885.69-14.13--
Lantheus Holdings Inc1.54bn254.32m5.63bn808.0023.074.8317.743.663.523.5221.6216.840.79087.964.481,901,855.0013.099.8714.9511.3364.0460.4416.5512.865.46--0.32750.0018.3234.59-4.3558.0629.27--
Glaukos Corp404.52m-123.68m5.93bn995.00--7.71--14.66-2.31-2.317.4213.460.42591.796.85406,555.80-13.02-11.24-14.06-12.0475.7573.54-30.57-36.685.62--0.083--21.8510.10-8.70--5.93--
Guardant Health Inc774.00m-416.55m6.23bn2.00k------8.04-3.38-3.386.28-2.030.50774.277.74387,191.60-27.33-24.20-32.00-26.8361.3463.23-53.82-91.243.76-38.581.29--31.0428.088.98--10.58--
Bruker Corp3.45bn79.60m6.64bn11.40k83.383.6523.731.930.52520.525222.8311.990.66021.565.74302,395.601.536.802.049.2049.2850.002.329.660.716413.770.533110.8713.5610.19-73.53-10.529.574.56
Stevanato Group SpA1.31bn146.67m6.88bn5.52k46.914.1629.075.230.53750.53754.826.060.49582.942.72238,105.605.538.027.0010.9428.7131.0111.1613.241.26--0.21746.821.7215.53-19.1324.6133.52--
Bio Rad Laboratories Inc2.54bn-2.16bn7.00bn7.70k--1.06--2.75-76.20-76.2090.48241.720.22961.505.84330,010.40-19.553.00-20.453.1553.6855.37-85.1714.514.430.10310.15250.00-3.922.11-189.37--13.91--
Repligen Corp650.43m-22.98m7.31bn1.78k--3.68104.5211.25-0.4124-0.412411.5735.340.22821.814.94365,820.60-0.80613.28-0.85573.7051.1554.24-3.5312.375.79--0.21060.000.328518.61-171.68--5.25--
Caris Life Sciences Inc452.50m-371.16m7.37bn--------16.28-1.34-1.341.63-1.27----------------46.71---60.43--0.8285-4.4216.39--34.67--18.22------
Globus Medical Inc2.51bn185.56m7.73bn5.30k42.731.8917.153.081.341.3418.1130.200.52011.054.70473,737.803.844.704.375.1869.0070.597.399.732.7220.570.00010.0060.6226.25-16.19-7.8810.29--
Masimo Corp1.97bn-276.60m8.84bn3.60k--9.33--4.48-5.17-9.2136.5117.460.75172.426.30548,222.30-10.543.29-13.173.9950.5053.94-14.024.561.622.120.40750.002.2617.43-474.11---6.75--
Henry Schein Inc12.67bn407.00m9.18bn25.00k22.822.7113.170.72443.223.22100.1227.081.234.917.86506,760.003.885.436.389.1931.6030.233.163.980.75256.940.37990.002.714.88-6.25-11.0619.66--
Data as of Jul 11 2025. Currency figures normalised to Bruker Corp's reporting currency: US Dollar USD

Institutional shareholders

44.61%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 31 Mar 202512.38m8.17%
The Vanguard Group, Inc.as of 31 Mar 202510.37m6.84%
BlackRock Fund Advisorsas of 31 Mar 202510.20m6.73%
Fidelity Management & Research Co. LLCas of 31 Mar 20259.81m6.47%
Pallas Capital Advisors LLCas of 31 Mar 20259.50m6.26%
The London Company of Virginia LLCas of 31 Mar 20254.14m2.73%
SSgA Funds Management, Inc.as of 31 Mar 20253.83m2.53%
Sculptor Capital LPas of 31 Mar 20252.60m1.71%
Brown Advisory LLCas of 31 Mar 20252.40m1.59%
AllianceBernstein LPas of 31 Mar 20252.39m1.58%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.